Canopy Growth Narrows Losses and Bolsters Balance Sheet as Canadian Cannabis Sales Rise
Claim 50% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
Canopy Growth ( (TSE:WEED) ) has provided an announcement.
Canopy Growth reported third-quarter fiscal 2026 results showing a 49% year-over-year narrowing of net loss and a 17% improvement in adjusted EBITDA loss, supported by double-digit growth in Canadian medical and adult-use cannabis net revenue and disciplined cost-cutting. Consolidated net revenue held at $75 million, with cannabis sales up 4% and strong sequential growth at Storz & Bickel driven by seasonal demand and the new VEAZY vaporizer, partially offset by weaker European cannabis sales and lower gross margins; the company closed a strategic recapitalization extending all debt maturities to 2031, maintained a solid cash position of $371 million with net cash of $146 million, and reiterated that cost structure “right-sizing” and expected growth position it to achieve positive adjusted EBITDA in fiscal 2027 as it moves to close the MTL Cannabis acquisition and bolster its global platform.
The most recent analyst rating on (TSE:WEED) stock is a Hold with a C$1.50 price target. To see the full list of analyst forecasts on Canopy Growth stock, see the TSE:WEED Stock Forecast page.
Spark’s Take on TSE:WEED Stock
According to Spark, TipRanks’ AI Analyst, TSE:WEED is a Neutral.
Canopy Growth’s overall stock score is primarily impacted by its poor financial performance, with significant profitability and cash flow challenges. While technical indicators suggest some short-term bullish momentum, the negative P/E ratio and lack of dividend yield weigh heavily on the valuation. The company’s strategic improvements in Canada are promising, but international market challenges and regulatory risks remain concerns.
To see Spark’s full report on TSE:WEED stock, click here.
More about Canopy Growth
Canopy Growth Corporation is a Canadian cannabis company operating in both medical and adult-use markets, with a focus on branded products such as infused pre-rolls and vape formats under labels including Tweed and 7ACRES. The company also owns Storz & Bickel, a premium vaporizer manufacturer, and pursues international cannabis opportunities, particularly in Europe, while maintaining a significant presence in its home Canadian market.
Average Trading Volume: 4,223,437
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$583.5M
See more data about WEED stock on TipRanks’ Stock Analysis page.
